Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events

Clinical trial NCT00206089 · TERMINATED

Trial details

NCT number: NCT00206089
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Thromboembolism

Start date: 2005-09-01
Primary completion: 2006-08-01
Enrollment: 3300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.